Please could you introduce yourself and tell us what inspired your latest research into COVID-19?
My name is Paolo De Coppi. I am a pediatric surgeon, working mainly with children that have congenital or sometimes acquired diseases, treating them with surgery when possible.
At the beginning of the pandemic, while it was quite clear that COVID did not mainly affect children, we had a number of children presenting with symptoms that were similar to appendicitis, but without its classical features.
We started imaging this and discovered that there was a slightly different manifestation of COVID in children that was more focused on the GI tract. There were big lymph nodes in these childrens tummies, and that was what was causing tummy pain, not appendicitis. We reported our observations in a letter to the Lancet early in the pandemic in the Lancet Child and Adolescent Health issue.
I wanted to know why children did not have respiratory symptoms in this manifestation, only GI symptoms. Soon after that, a few publications were showing that SARSCoV2 could actually replicate in the GI tract. For me, it was important to understand how the virus circulated from the airway to the stomach, to the intestine. The point of entry to the intestine is the stomach. We wanted to determine whether the virus could replicate there because, in that way, children also can be passing on the disease oral-fecally, rather than through classical respiratory transmission.
We are a tissue engineering laboratory. We work with cells to build tissues and organs enabling us to test hypotheses with various organs, particularly on the GI tract. At that time, we had just had a paper accepted on building an intestinal mucosa with Vivian Lee in Nature medicine. We thought that if we could build a sort of mini stomach, we could test this hypothesis.
Next, we collaborated with one of the groups in Italy that first isolated the COVID virus in the first wave of the pandemic. We sent over this engineered mini gut model and they were able to not only infect them but also show that the virus was happily replicating, particularly in organoids derived from children.
Image Credit: visivastudio/Shutterstock.com
I think all doctors and people in the field of biomedicine, from nurses to scientists, felt their responsibility to help in this unique situation. We all wanted to use our skills to help where we could. At that time I had a lot of people in the lab from all over the world who felt useless to just be at home, not being helpful, because classical research could not continue. We wanted to help.
We thought that these engineered tissues we had in the laboratory could be used to test infection, in collaboration with experts on the virus, to try to understand what was going on better. It was very rewarding for everyone in the lab to see that what they were making was useful both from an engineering perspective and as a tool for understanding the infection. This was extremely rewarding from a personal point of view because it felt like we were doing something significant.
Organoids are like small organs, although they cannot replicate all the functions of the organs. You can culture cells from a tissue or an organ in a spheroid. These spheroids form to replicate some of the functions of the organs, and typically, these are the most important functions.
For example, for the gut, one of the most important functions is that of the epithelium because the epithelium absorbs the nutrients and carries out digestion. The organoids need to include the epithelium of the gut. The gut grows as small organs in which most of the functions of the epithelium are replicated.
That is what happened with the virus. The virus penetrates through the epithelium of the intestine. Therefore, if you can replicate that in vitro, you can show how the infection works.
Organoid research has taken over, thanks to some of the leading laboratories in the world. One of those that I want to mention because it was one of the first studies on the epithelium of the gut is Hans Clevers in Utrecht. He is one of the leaders in this field who showed that you can take a biopsy from an intestine and then grow these organoids, almost forever in culture.
This is extremely useful because you can understand not only the normal physiology of the gut but you can, for example, study why a cancer developed from a particular epithelium. You can study what happens when dysregulation comes into place.
You can also study diseases like we have done, for example, infection. Inflammatory bowel disease can also be studied, or you can study situations where you have an ischemic event and you have damage to the epithelium or the intestine. Therefore you can see how the epithelium regenerates and replicates.
We are touching on something here that has not been explored completely yet. There is a so called gut brain access, and this is regulated in some way. The studies out there seem to show that, for example, the bacteria growing in your gut can condition some of the brain function.
This is something that needs to be explored further as at the moment things are not so clear. This organoid model may help with the understanding of how some of the secretory factors of the epithelium in the gut may condition other cell types, like the organoids of the brain. This is really at the cutting edge of research. Some groups are working on this, but there is not yet a clear representation of how the gut influences the brain through this access.
Image Credit: Giovanni Giobbe
This is very important and is thanks to the access to the material here that we have in the UK. I think it is pretty unique that we have access to the developing stages of a human fetus. This is so important because it helps us to understand how the human gut develops. While there are similarities with other mammals, the human gut has some important unique differentiation pathways from other species.
We were able to obtain tissues from the early phase of development and early in the postnatal period from tissue that was discarded from surgery, as well as adult tissue from biopsies. Then we were able to form organoids from all these stages of development, discovering that the behavior of these organoids was understandably very different at different stages. The pediatric cells actually have some similarities with the fetal cells, which are completely lost in the adult.
This is an important question. We have demonstrated the differences, but what we do not know yet is the reason for those differences. It looks like the nave stem cells in the fetus and pediatrics express receptors that are useful to the virus for getting in. In the adult, the cells lose this expression.
Once we grow the cells and make them different from a specialized epithelium, a specialized mucosa, these differences disappear. As progenitors, there are receptors that the virus needs to enter into the cells that are not there in the adult, so that is something that is clearly different. Why is this different? We do not know yet.
One very clear answer to this is the polarization of the organoids. When you grow organoids, they grow like a sphere. This sphere has the epithelium that is normally present in the intestine looking inside. The lumen inside the sphere is the lumen of the tube of our intestine or our gut in general.
The problem with this is that when we started infection in this way, we could not see much infection because the surface of the epithelium was inside the sphere. The virus could not gain access easily. We had to invert the polarization of the epithelium and make the organoids look inside out.
When we changed that we saw much more efficient SARS-CoV-2 infection in the organoids. This was a clear biological answer to the question: how can we improve the infection rate and make it similar to in vivo?
We believe the next step will be to have these organoids for two things. The first is as a predictive model. We are seeing just now with the Omicron strain the different mutations the virus can have. It can lead to completely different clinical manifestations. Can we predict the way that the virus behaves with these in vitro models? We are really keen to study the different variants with this model and see if they have a different impact on different ages or systems.
The second thing is can we use some protectors, for example, to decrease the virus penetration to the epithelium. This is outside my field of expertise, but we can offer this model to a specialized lab that can work on this. We want to get more funding to try to use this system for predictions within this and other pandemics.
Image Credit: Corona Borealis Studio/Shutterstock.com
I strongly believe that this is very important for that. At the moment, for example, we are observing a lot of young people and children getting infected and some of them may have negative swabs in their airway because that is not the primary target of the virus.
I think our model can further help understand this problem and the role of the GI system in the pandemic, particularly in children.
We are trying to go back to the primary aim of this work, which is to engineer mini stomachs. Mini stomachs will be beneficial for children that are born without a stomach or have a very small stomach. In the operation where we make the stomach bigger, we use the intestine, but the intestine is a different part of the body and does not work in the same way as the stomach. Those children continue to have problems.
Adults can also lose their stomachs, for example, because of cancer. At the moment, to treat this the stomach is completely taken out and replaced with the intestine, but those adults struggle to feed because they do not have a sac to digest the food. By doing this research, we could reach a stage where we could replicate the stomach.
In the meantime, developing a more complex stomach, for example, including inflammatory cells or endothelial cells, could help us understand the relationship between COVID-19 and other cell types that are present in the stomach more. We know that, for example, the endothelium can be affected. We know that there has been a local reaction described. We want to see if those types of manifestations can be replicated in vitro.
The first direction is to acquire more funding and to use these organoids as a model to test the different variants, in particular how the different variants work in a child's stomach. That could help predict what will happen in the future and understand if this is a minor disease to the GI tract, or if it can actually lead to cell death or cell apoptosis, and so on.
The second direction is within regenerative and tissue engineering in which we are trying to create a more complex mini stomach that could be used to replace missing stomachs in both adults and children.
This is a work of many and it is all thanks to collaborating with people of different expertise. To get through difficult moments, the best thing to do is to create networks, as many have done, and try to answer questions by working together.
If you want to find a positive element from this pandemic, there has never been a better moment in science than this, as it has really pushed people to work together.
Paolo De Coppi is the Nuffield Chair of Paediatric Surgery, the NIHR Professor of Paediatric Surgery, and Consultant Paediatric Surgeon at the Great Ormond Street Hospital. He is the President Elect of the European Pediatric Surgical Association and the Head of the Surgery Unit, Stem Cells & Regenerative Medicine Section, Developmental Biology& Cancer Programme at the UCL Great Ormond Institute of Child Health. In 2020 he has become the first Paediatric Surgeon to be elected Fellow of the Academy of Medical Sciences.
Professor De Coppi trained at Boston Children's Hospital, the Academic Medical Center (Amsterdam, NL), and Padua University (Italy), and has a special interest in congenital malformations and their treatment using minimally invasive techniques. He is a patron for TOFS and CDHUK and has focused his research interests on stem cells and tissue engineering by trying to find new modalities for the treatment of complex congenital anomalies.
He identified stem cells from amniotic fluid and he has described methods to decellularised several organs and tissue such as the kidney, intestine, liver, pancreas, and lung. In 2010 he was part of the team that performed the first successful transplantation of a tissue-engineered trachea on a child at the Great Ormond Street Hospital. He has published more than 350 peer-reviewed articles (h-index 65) in journals such as Nature, Nature Biotechnology, The Lancet, Nature Biomedical Engineering, Nature Communications, and Cells Stem Cells; supervised more than 35 research fellow and Ph.D. students; and has been awarded various national and international grants in excess of 30 million. He is on the editorial boards of Stem Cell Development, Journal of Pediatric Surgery, Pediatric Surgery International, and Fetal and Maternal Medicine Review. As of 2011, he has been the senior associate editor for Stem Cell Translational Medicine.
See the original post here:
Using lab-grown stomachs to shed light on the symptoms of COVID-19 - News-Medical.Net
- Biology of stem cells: an overview - PMC - National Center for ... - March 26th, 2024
- Iron Limitation Preserves Youthfulness of Blood Stem Cells - Mirage News - March 13th, 2024
- Mini organs grown from stem cells of unborn babies for the first time in breakthrough - The Mirror - March 9th, 2024
- The Effect of Short-Term NAD3 Supplementation on Circulating Adult Stem Cells in Healthy Individuals Aged 40-70 ... - Cureus - March 7th, 2024
- University of Liverpool Spin-Out Emerges, Pioneering Novel Adult Stem Cell-Based Therapies - India Education Diary - March 7th, 2024
- Scientists have used cells from fluid drawn during pregnancy to grow mini lungs and other organs - Yahoo News Canada - March 6th, 2024
- Japan approves new stem cell-based Alzheimer's therapy By Proactive Investors - Investing.com Australia - January 20th, 2024
- Cyberstalking pits Harvard professor against PubPeer Retraction ... - Retraction Watch - December 5th, 2023
- 10 functional health predictions for 2024, according to a doctor and ... - 1330 WFIN - December 5th, 2023
- See the Brain Like Never Before in This Gorgeous Art - Scientific American - December 5th, 2023
- Geron Announces Publication in The Lancet of Results from the ... - BioSpace - December 5th, 2023
- Stem cell injections could be the key to curing MS - Freethink - December 3rd, 2023
- Jaypirca (pirtobrutinib) Now Approved by U.S. FDA for the ... - Investors | Eli Lilly and Company - December 3rd, 2023
- Comparative Efficacy and Safety of Four JAK Inhibitors for ... - HealthDay - December 3rd, 2023
- City lights up for Francis on Anthony Nolan's birthday - Liverpool Express - December 3rd, 2023
- NOT-AR-23-022: Request for Information on Themes for the NIAMS ... - National Institutes of Health (.gov) - December 3rd, 2023
- December 2023: Intramural Papers of the Month - Environmental Factor Newsletter - December 1st, 2023
- CNA Explains: What is cord blood banking and why do parents do it? - CNA - December 1st, 2023
- Regulation of myogenesis and adipogenesis by the electromagnetic ... - Nature.com - December 1st, 2023
- The effects of vitamin K on bone health - News-Medical.Net - December 1st, 2023
- Dr Hurwitz on Ongoing Investigations of the Use of CAR T-Cell ... - OncLive - December 1st, 2023
- Mitophagy in human health, ageing and disease - Nature.com - December 1st, 2023
- Adult Stem Cells - Stem Cells and the Future of Regenerative Medicine ... - November 29th, 2023
- Navigating The Regulatory Landscape Of Longevity Health Products ... - Mondaq News Alerts - November 29th, 2023
- MS breakthrough could lead to treatments that halt disease's ... - inews - November 29th, 2023
- Reprogramming tissue mechanically to promote wound healing - Phys.org - November 29th, 2023
- Latest Advances in Arthritis Diagnosis and Treatment at American ... - HealthDay - November 29th, 2023
- Sex-associated differences in frequencies and prognostic impact of ... - Nature.com - November 29th, 2023
- Hematologists Dive into the Current Treatment Landscape - OncLive - November 29th, 2023
- Team discovers protein crucial for B cell differentiation and antibodies - Phys.org - November 29th, 2023
- Science Talk - I survived cancer as a child and now I'm working to ... - The Institute of Cancer Research - November 29th, 2023
- First Edition: Nov. 29, 2023 - KFF Health News - November 29th, 2023
- Symptoms: Unilateral Hearing Loss and Tinnitus : The Hearing Journal - LWW Journals - November 29th, 2023
- Mitigation of sepsis-induced acute lung injury by BMSCs | IJN - Dove Medical Press - November 29th, 2023
- A Case of a Constricted Vessel: The Impact of Acute Myeloid ... - Cureus - November 29th, 2023
- Mum brushed off fatigue after having baby but fall sparked deadly diagnosis - The Mirror - November 29th, 2023
- How heritable is the epigenome? - Drug Discovery News - November 29th, 2023
- The Blueprint of Regeneration: Scientists Discover How to Turn Stem Cells Fate - Revyuh - November 27th, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - Marketscreener.com - November 27th, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - PharmiWeb.com - November 25th, 2023
- COVID-19 Pandemic's Adverse Effect on Bone Health in Young ... - HealthDay - November 25th, 2023
- Sickle cell breakthrough - The Indian Express - November 25th, 2023
- Wall thickness analysis method for judging the degree of lower ... - Nature.com - November 25th, 2023
- Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference - Yahoo Finance - November 23rd, 2023
- Disease Transmission and Diagnosis of Zika Virus - Cureus - November 23rd, 2023
- Gene-editing therapy for sickle cell earns conditional approval in UK - Sickle Cell Disease News - November 23rd, 2023
- Stem Cell Therapy Developed in Korea Begins Treatment for ... - Newswire - November 21st, 2023
- Efficacy of ADSC-CM in Patients with Telogen Effluvium | SCCAA - Dove Medical Press - November 21st, 2023
- BrainStorm Cell Therapeutics Announces In-Person Meeting with ... - PR Newswire - November 21st, 2023
- The Impact of CAR T Cell Therapy on Managing R/R LBCL - OncLive - November 21st, 2023
- Mansour bin Zayed witnesses inauguration of ADSCC Bone Marrow Transplant & Cellular Therapy Congress 2023 - ZAWYA - November 21st, 2023
- Listeria: Who is most susceptible? What are the Symptoms? What ... - Food Poison Journal - November 21st, 2023
- Scope Of Issued Patents May Be Limited By Prosecution Estoppel ... - Mondaq News Alerts - November 21st, 2023
- Qrons Announces the Addition of Professor Shiri Navon-Venezia to ... - StreetInsider.com - November 21st, 2023
- Financially strapped Athersys raises $10.4M - cleveland.com - November 19th, 2023
- From the India Today archives (2010) | How stem cells can save your life - India Today - November 19th, 2023
- Inactivation of the tumor suppressor gene Apc synergizes with H ... - Science - November 19th, 2023
- The Origins of Multiple Myeloma and Why it Matters - HealthTree For AML - Acute Myeloid Leukemia - November 19th, 2023
- Treatment Considerations With TROP2-Targeted Therapy - OncLive - November 19th, 2023
- Athersys narrows loss, raises $10.4 million during third quarter to ... - The Business Journals - November 17th, 2023
- Who was Dolly the Sheep and what happened to her? The story of ... - BBC Countryfile Magazine - November 17th, 2023
- UK first to approve CRISPR treatment for diseases: what you need to ... - Nature.com - November 17th, 2023
- 1st sickle cell patient to be given therapy restoring fetal hemoglobin - Sickle Cell Disease News - November 15th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates - Century - Benzinga - November 13th, 2023
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer - Yahoo Finance - November 11th, 2023
- Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in... - November 11th, 2023
- AAO 2023: Paul Runge and his ROP treatments in the Ukraine - Modern Retina - November 11th, 2023
- The Evolutionary Reasons We Are Drawn To Horror Movies and ... - Slashdot - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - GlobeNewswire - November 11th, 2023
- Century Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 9th, 2023
- NYU Langone Health Performs World's First Whole-Eye & Partial ... - NYU Langone Health - November 9th, 2023
- BrainStorm to Announce Third Quarter 2023 Financial Results and ... - BioSpace - November 9th, 2023
- Can we cut cost and pain of IVF? Start-up CEO tries out own ... - Genetic Literacy Project - November 9th, 2023
- Jasper Therapeutics Reports Third Quarter 2023 Financial Results ... - BioSpace - November 9th, 2023
- Impaired neural stress resistance and loss of REST in bipolar ... - Nature.com - November 9th, 2023
- Functional genomics and systems biology in human neuroscience - Nature.com - November 9th, 2023
- Trial launched to test CAR T-cell therapy in dogs diagnosed with ... - EurekAlert - November 9th, 2023
- The-Gut's-Lasting-Impact-on-Severe-COVID-19-Immune-Response - Infectious Disease Special Edition - November 9th, 2023
- Emerging Cure for Sickle Cell on its Way to FDA Approval, Carries ... - Dallasweekly - November 7th, 2023
- The science works, but will we pay for it? - Irish Medical Times - November 7th, 2023
Recent Comments